Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.
|
Nat Genet
|
2003
|
5.16
|
2
|
De novo mutations in histone-modifying genes in congenital heart disease.
|
Nature
|
2013
|
5.15
|
3
|
Atenolol versus losartan in children and young adults with Marfan's syndrome.
|
N Engl J Med
|
2014
|
5.11
|
4
|
Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.
|
Nat Genet
|
2006
|
4.68
|
5
|
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome.
|
Nature
|
2010
|
4.38
|
6
|
Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics.
|
Circulation
|
2007
|
4.34
|
7
|
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.
|
Nat Genet
|
2007
|
3.47
|
8
|
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia.
|
J Exp Med
|
2008
|
3.24
|
9
|
Noonan syndrome and related disorders: genetics and pathogenesis.
|
Annu Rev Genomics Hum Genet
|
2005
|
3.02
|
10
|
PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.
|
Am J Hum Genet
|
2002
|
2.81
|
11
|
Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease.
|
Am J Hum Genet
|
2005
|
2.75
|
12
|
Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair.
|
Nat Genet
|
2009
|
2.57
|
13
|
Noonan syndrome: clinical features, diagnosis, and management guidelines.
|
Pediatrics
|
2010
|
2.56
|
14
|
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia.
|
Blood
|
2004
|
2.19
|
15
|
The phosphatase SHP2 regulates the spacing effect for long-term memory induction.
|
Cell
|
2009
|
2.19
|
16
|
Noonan syndrome.
|
Lancet
|
2013
|
2.13
|
17
|
Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome.
|
Nat Genet
|
2002
|
1.96
|
18
|
Genetics of congenital heart disease: the glass half empty.
|
Circ Res
|
2013
|
1.90
|
19
|
Noonan syndrome and clinically related disorders.
|
Best Pract Res Clin Endocrinol Metab
|
2011
|
1.82
|
20
|
The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease.
|
Blood
|
2005
|
1.80
|
21
|
Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
|
Hum Mutat
|
2004
|
1.80
|
22
|
Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype.
|
Am J Hum Genet
|
2006
|
1.78
|
23
|
A restricted spectrum of NRAS mutations causes Noonan syndrome.
|
Nat Genet
|
2009
|
1.71
|
24
|
Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice.
|
Arterioscler Thromb Vasc Biol
|
2008
|
1.64
|
25
|
Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome.
|
Hum Mutat
|
2007
|
1.56
|
26
|
Cyclosporine attenuates cardiomyocyte hypertrophy induced by RAF1 mutants in Noonan and LEOPARD syndromes.
|
J Mol Cell Cardiol
|
2011
|
1.55
|
27
|
Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling.
|
Cell Stem Cell
|
2012
|
1.54
|
28
|
Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms.
|
Ann N Y Acad Sci
|
2010
|
1.54
|
29
|
Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype.
|
Am J Hum Genet
|
2010
|
1.53
|
30
|
Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis.
|
J Clin Endocrinol Metab
|
2004
|
1.53
|
31
|
Parents and clinicians underestimate distress and depression in children who had a transplant.
|
Pediatr Transplant
|
2005
|
1.50
|
32
|
Phosphatase-defective LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development.
|
Hum Mol Genet
|
2008
|
1.50
|
33
|
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum.
|
Hum Mutat
|
2009
|
1.49
|
34
|
Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate.
|
J Biol Chem
|
2002
|
1.40
|
35
|
Marfan's syndrome and related disorders--more tightly connected than we thought.
|
N Engl J Med
|
2006
|
1.38
|
36
|
Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back.
|
Am J Med Genet A
|
2010
|
1.36
|
37
|
Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass.
|
J Bone Miner Res
|
2006
|
1.28
|
38
|
Germ-line and somatic PTPN11 mutations in human disease.
|
Eur J Med Genet
|
2005
|
1.27
|
39
|
Neurofibromatosis-Noonan syndrome: molecular evidence of the concurrence of both disorders in a patient.
|
Am J Med Genet A
|
2005
|
1.19
|
40
|
Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice.
|
Hum Mol Genet
|
2002
|
1.18
|
41
|
Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy.
|
Am Heart J
|
2013
|
1.14
|
42
|
SOS1 mutations in Noonan syndrome: molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations.
|
Hum Mutat
|
2011
|
1.12
|
43
|
Effect of copy number variants on outcomes for infants with single ventricle heart defects.
|
Circ Cardiovasc Genet
|
2013
|
1.11
|
44
|
Transcription factor Ap-2alpha is necessary for development of embryonic melanophores, autonomic neurons and pharyngeal skeleton in zebrafish.
|
Dev Biol
|
2004
|
1.11
|
45
|
Comparison of parent and child reports of emotional trauma symptoms in pediatric outpatient settings.
|
Pediatrics
|
2005
|
1.11
|
46
|
Cathepsin K deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice.
|
Arterioscler Thromb Vasc Biol
|
2011
|
1.11
|
47
|
Transgenic Drosophila models of Noonan syndrome causing PTPN11 gain-of-function mutations.
|
Hum Mol Genet
|
2006
|
1.07
|
48
|
Expression of Tfap2d, the gene encoding the transcription factor Ap-2 delta, during mouse embryogenesis.
|
Gene Expr Patterns
|
2003
|
1.07
|
49
|
Ash2l interacts with Tbx1 and is required during early embryogenesis.
|
Exp Biol Med (Maywood)
|
2010
|
1.06
|
50
|
Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis.
|
Hum Mutat
|
2010
|
1.05
|
51
|
Transcription factor Ap2delta associates with Ash2l and ALR, a trithorax family histone methyltransferase, to activate Hoxc8 transcription.
|
Proc Natl Acad Sci U S A
|
2008
|
1.05
|
52
|
Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromes.
|
Hum Mol Genet
|
2008
|
1.04
|
53
|
A restricted spectrum of mutations in the SMAD4 tumor-suppressor gene underlies Myhre syndrome.
|
Am J Hum Genet
|
2012
|
1.04
|
54
|
Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans.
|
Am J Hum Genet
|
2010
|
0.99
|
55
|
The genetics of congenital heart disease: a review of recent developments.
|
Curr Opin Cardiol
|
2007
|
0.98
|
56
|
Age-dependent germline mosaicism of the most common noonan syndrome mutation shows the signature of germline selection.
|
Am J Hum Genet
|
2013
|
0.97
|
57
|
Role of copy number variants in structural birth defects.
|
Pediatrics
|
2012
|
0.96
|
58
|
Basic concepts and potential applications of genetics and genomics for cardiovascular and stroke clinicians: a scientific statement from the American Heart Association.
|
Circ Cardiovasc Genet
|
2015
|
0.93
|
59
|
Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome.
|
Am J Hum Genet
|
2004
|
0.92
|
60
|
Economic and safety implications of introducing fast tracking in congenital heart surgery.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
0.92
|
61
|
Induced pluripotent stem cell-derived cardiomyocytes as models for genetic cardiovascular disorders.
|
Curr Opin Cardiol
|
2011
|
0.92
|
62
|
Novel functional interaction between Na+/H+ exchanger 1 and tyrosine phosphatase SHP-2.
|
Am J Physiol Regul Integr Comp Physiol
|
2007
|
0.89
|
63
|
Signaling to cardiac hypertrophy: insights from human and mouse RASopathies.
|
Mol Med
|
2012
|
0.88
|
64
|
Male infertility due to germ cell apoptosis in mice lacking the thiamin carrier, Tht1. A new insight into the critical role of thiamin in spermatogenesis.
|
Dev Biol
|
2004
|
0.88
|
65
|
Evaluation of pulmonary artery banding in the setting of ventricular septal defects and severely elevated pulmonary vascular resistance.
|
Congenit Heart Dis
|
2006
|
0.88
|
66
|
Concise review: drug discovery in the age of the induced pluripotent stem cell.
|
Stem Cells Transl Med
|
2014
|
0.86
|
67
|
MiST: a new approach to variant detection in deep sequencing datasets.
|
Nucleic Acids Res
|
2013
|
0.84
|
68
|
A PTPN11 allele encoding a catalytically impaired SHP2 protein in a patient with a Noonan syndrome phenotype.
|
Am J Med Genet A
|
2014
|
0.82
|
69
|
Ablation of cathepsin k activity in the young mouse causes hypermineralization of long bone and growth plates.
|
Calcif Tissue Int
|
2009
|
0.82
|
70
|
The Good SHP2 Association: a porthole into the genetics of congenital heart disease.
|
Circ Cardiovasc Genet
|
2012
|
0.81
|
71
|
Fgfr3 is a transcriptional target of Ap2delta and Ash2l-containing histone methyltransferase complexes.
|
PLoS One
|
2009
|
0.81
|
72
|
Neonatal Marfan syndrome : in utero presentation with aortic and pulmonary artery dilatation and successful repair of an acute flail mitral valve leaflet in infancy.
|
Pediatr Cardiol
|
2006
|
0.80
|
73
|
Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: palliative treatment with a rapamycin analog.
|
Am J Med Genet A
|
2015
|
0.78
|
74
|
Thiamine pyrophosphate: an essential cofactor in the mammalian metabolism of 3-methyl-branched fatty acids--implications for thiamine deficiencies?
|
Adv Exp Med Biol
|
2003
|
0.78
|
75
|
Absence of PTPN11 mutations in 28 cases of cardiofaciocutaneous (CFC) syndrome.
|
Hum Genet
|
2002
|
0.78
|
76
|
A trial of vitamin A therapy to facilitate ductal closure in premature infants.
|
J Pediatr
|
2003
|
0.78
|
77
|
Counteracting effects operating on Src homology 2 domain-containing protein-tyrosine phosphatase 2 (SHP2) function drive selection of the recurrent Y62D and Y63C substitutions in Noonan syndrome.
|
J Biol Chem
|
2012
|
0.77
|
78
|
Genetics of congenital heart disease.
|
Curr Opin Cardiol
|
2016
|
0.77
|
79
|
Char syndrome, a familial form of patent ductus arteriosus, with a new finding: hypoplasia [corrected] of the 3rd finger.
|
Anadolu Kardiyol Derg
|
2012
|
0.75
|
80
|
Multiple thoracic aortic aneurysms after mediastinitis in an infant after repair of coarctation of the aorta.
|
J Thorac Cardiovasc Surg
|
2008
|
0.75
|